Acupoint selection rules for acupoint application in lung diseases in the post-epidemic era

Journal Title: TMR Integrative Medicine - Year 2022, Vol 6, Issue 2

Abstract

Objective: To summarize the rules of acupoint selection of acupoint application to prevent and treat lung diseases under the background the post-epidemic era using data-mining technology. Method: The CNKI, Wanfang database, and VIP database were searched for clinical study articles on lung diseases treated by acupoint application published in the past 5 years. Data-eligible papers were extracted to establish a database of acupoint application for lung disease using Microsoft Excel 2019, with the goal of analyzing the frequency of acupoints, acupoint-meridian association, acupoint-location association, specific acupoint frequency, and cluster analysis. Association rules, consisting of acupoints with an application frequency of ³ 10, were devised by the Apriori algorithm to explore the correlation between acupoint groups and to analyze the rules of the compatibility of acupoint prescriptions. Results: A total of 229 eligible papers met our inclusion criteria. Forty-seven acupoints were applied, for a total frequency of acupoints of 1,035 times. Among these, acupoints for lung diseases were primarily distributed in the back-and-waist and chest-and-abdomen areas. From the analysis of the association rules, we obtained four groups of acupoint association rules based on acupoint clusters with a frequency ³ 10 and found that Feishu (BL 13), Tiantu (CV 22), Dazhui (GV 14), Dingchuan (EX-B1), and Danzhong (CV 17) constitute the core acupoints of prescriptions for clinical acupoint application to prevent and treat lung diseases. Conclusion: It is clearly shown that the core acupoints are relatively concentrated and that the selected acupoints were mainly locally selected, which could be a matching reference for the long-term prevention and treatment of lung diseases, including COVID-19.

Authors and Affiliations

An-Hong Dai, Chun-Hong Luo, Yi-Hao Zhou, Gan Huang, Zhi-Lin Huang, Xue-Lian Zhang, Mei-Fang Liu, Jing Shi, You-Long Xiong

Keywords

Related Articles

The prognosis and survival of integrated traditional Chinese and Western medicine on glioma: a meta-analysis

Objective: To systematically access the effects of integrated traditional Chinese and western medicine treatment versus western medicine treatment alone in glioma. Methods: Published randomized controlled trials were inc...

Application of external treatment of traditional Chinese medicine in the treatment of cancer-related fatigue

External treatment of traditional Chinese medicine (TCM), also known as external treatment of internal diseases, has many advantages, such as simple, easy to operate, cost-effective and so on. Therefore, external treatm...

TMR Integrative Medicine

Eczema (Nār Fārsī) is characterized by itching, lichenification, scaling, oedema and erythema. Corticosteroids are the mainstay of current management of this disease in modern medicine, which is also limited due to its s...

A Case of Plasma cell variant Castleman Disease

Castleman disease, also known as angiofollicular lymph node hyperplasia, is a rare lymphoproliferative disease with a poorly understood etiology. We herein report a 27-year-old male with a six months history of painless...

Utilization, practice of herbal medicine in patients with type 2 diabetes mellitus in Kuwait and their perceptions

Background: Herbal medicine has become a popular treatment among patients with chronic diseases like diabetes mellitus worldwide. Many patients with diabetes mellitus use herbal medicine without consulting their health p...

Download PDF file
  • EP ID EP701898
  • DOI 10.12032/TMRIM202206002
  • Views 181
  • Downloads 0

How To Cite

An-Hong Dai, Chun-Hong Luo, Yi-Hao Zhou, Gan Huang, Zhi-Lin Huang, Xue-Lian Zhang, Mei-Fang Liu, Jing Shi, You-Long Xiong (2022). Acupoint selection rules for acupoint application in lung diseases in the post-epidemic era. TMR Integrative Medicine, 6(2), -. https://www.europub.co.uk/articles/-A-701898